A Phase III randomised, controlled trial of exercise during chemotherapy for patients commencing first-line treatment for ovarian cancer.

See ANZCTR for full trial details >

 

Trial Summary:

The aim of this study is to determine effect of a structured exercise intervention on physical wellbeing at post-intervention and 6 and 12 months post-randomisation.

Supported By:

This study is a collaboration between Griffith University, the Australia New Zealand Gynaecological Oncology Group (ANZGOG) and the NHMRC Clinical Trials Centre (CTC), University of Sydney

Eligibility:

Patients ≥18 years, newly diagnosed with epithelial ovarian, primary peritoneal or fallopian tube cancer and scheduled for chemotherapy.

Registration ID:

ACTRN12614001311640

Participation:

Australia

Australian Lead Group:

ANZGOG

Status:

In follow-up

Activation Date:

2014

Chairs:

Prof Sandi Hayes

Contact:

echo.study@sydney.edu.au